Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro-Oncology. 2023;25(Supplement_4):iv1–99. https://doi.org/10.1093/neuonc/noad149.
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 2018;20(suppl_4):iv1–86. https://doi.org/10.1093/neuonc/noy131.
Article PubMed PubMed Central Google Scholar
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96. https://doi.org/10.1056/NEJMoa043330.
Article CAS PubMed Google Scholar
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62. https://doi.org/10.1016/s0140-6736(12)62167-9.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56. https://doi.org/10.1093/gerona/56.3.m146.
Article CAS PubMed Google Scholar
Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323–36. https://doi.org/10.1100/tsw.2001.58.
Article CAS PubMed PubMed Central Google Scholar
Soto-Perez-de-Celis E, Li D, Yuan Y, Lau YM, Hurria A. Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer. Lancet Oncol. 2018;19(6):e305–16. https://doi.org/10.1016/S1470-2045(18)30348-6.
•• Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293–312. https://doi.org/10.1200/jco.23.00933. ASCO report that outlines geriatric assessment tools and the outcomes from randomized controlled trials that assessed the efficacy geriatric-assessment informed management interventions.
Dale W, Williams GR, A RM, Soto-Perez-de-Celis E, Maggiore RJ, Merrill JK, et al. How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology. JCO Oncol Pract. 2021;17(6):336-44. https://doi.org/10.1200/op.20.00442.
Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7. https://doi.org/10.1093/gerona/62.7.722.
Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691–9. https://doi.org/10.1046/j.1532-5415.2001.49281.x.
Article CAS PubMed Google Scholar
Bellera CA, Rainfray M, Mathoulin-Pélissier S, Mertens C, Delva F, Fonck M, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–72. https://doi.org/10.1093/annonc/mdr587.
Article CAS PubMed Google Scholar
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95. https://doi.org/10.1503/cmaj.050051.
Article PubMed PubMed Central Google Scholar
Krenzlin H, Jankovic D, Alberter C, Kalasauskas D, Westphalen C, Ringel F, et al. Frailty in glioblastoma is independent from chronological age. Front Neurol. 2021;12: 777120. https://doi.org/10.3389/fneur.2021.777120.
Article PubMed PubMed Central Google Scholar
Deluche E, Leobon S, Lamarche F, Tubiana-Mathieu N. First validation of the G-8 geriatric screening tool in older patients with glioblastoma. Journal of Geriatric Oncology. 2019;10(1):159–63. https://doi.org/10.1016/j.jgo.2018.07.002.
Schneider M, Potthoff AL, Scharnbock E, Heimann M, Schafer N, Weller J, et al. Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival. J Neurooncol. 2020;149(3):421–7. https://doi.org/10.1007/s11060-020-03625-2.
Article CAS PubMed PubMed Central Google Scholar
Shahrestani S, Lehrich BM, Tafreshi AR, Brown NJ, Lien BV, Ransom S, et al. The role of frailty in geriatric cranial neurosurgery for primary central nervous system neoplasms. Neurosurg Focus. 2020;49(4):E15. https://doi.org/10.3171/2020.7.FOCUS20426.
Cloney M, D’Amico R, Lebovic J, Nazarian M, Zacharia BE, Sisti MB, et al. Frailty in geriatric glioblastoma patients: a predictor of operative morbidity and outcome. World Neurosurg. 2016;89:362–7. https://doi.org/10.1016/j.wneu.2015.12.096.
Botros D, Khalafallah AM, Huq S, Dux H, Oliveira LAP, Pellegrino R, et al. Predictors and impact of postoperative 30-day readmission in glioblastoma. Neurosurgery. 2022;91(3):477–84. https://doi.org/10.1227/neu.0000000000002063.
Article PubMed PubMed Central Google Scholar
Khalafallah AM, Huq S, Jimenez AE, Brem H, Mukherjee D. The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients. J Neurosurg. 2020;135(1):78–86. https://doi.org/10.3171/2020.5.JNS20766.
Katiyar V, Sharma R, Tandon V, Goda R, Ganeshkumar A, Suri A, et al. Impact of frailty on surgery for glioblastoma: a critical evaluation of patient outcomes and caregivers’ perceptions in a developing country. Neurosurg Focus. 2020;49(4):E14. https://doi.org/10.3171/2020.7.FOCUS20482.
Youngerman BE, Neugut AI, Yang J, Hershman DL, Wright JD, Bruce JN. The modified frailty index and 30-day adverse events in oncologic neurosurgery. J Neurooncol. 2018;136(1):197–206. https://doi.org/10.1007/s11060-017-2644-0.
Richardson AM, McCarthy DJ, Sandhu J, Mayrand R, Guerrero C, Rosenberg C, et al. Predictors of successful discharge of patients on postoperative day 1 after craniotomy for brain tumor. World Neurosurg. 2019;126:e869–77. https://doi.org/10.1016/j.wneu.2019.03.004.
Harland TA, Wang M, Gunaydin D, Fringuello A, Freeman J, Hosokawa PW, et al. Frailty as a predictor of neurosurgical outcomes in brain tumor patients. World Neurosurg. 2020;133:e813–8. https://doi.org/10.1016/j.wneu.2019.10.010.
Huq S, Khalafallah AM, Jimenez AE, Gami A, Lam S, Ruiz-Cardozo MA, et al. Predicting postoperative outcomes in brain tumor patients with a 5-factor modified frailty index. Neurosurgery. 2020;88(1):147–54. https://doi.org/10.1093/neuros/nyaa335.
Article PubMed PubMed Central Google Scholar
Huq S, Khalafallah AM, Patel P, Sharma P, Dux H, White T, et al. Predictive model and online calculator for discharge disposition in brain tumor patients. World Neurosurg. 2021;146:e786–98. https://doi.org/10.1016/j.wneu.2020.11.018.
Sastry RA, Pertsch NJ, Tang O, Shao B, Toms SA, Weil RJ. Frailty and outcomes after craniotomy for brain tumor. J Clin Neurosci. 2020;81:95–100. https://doi.org/10.1016/j.jocn.2020.09.002.
Bonney PA, Chartrain AG, Briggs RG, Jarvis CA, Ding L, Mack WJ, et al. Frailty is associated with in-hospital morbidity and nonroutine disposition in brain tumor patients undergoing craniotomy. World Neurosurg. 2021;146:e1045–53. https://doi.org/10.1016/j.wneu.2020.11.083.
Wang CM, Ma YL, Yang XY, Ji RQ, Gu WJ, Zhou JX. Association of preoperative frailty with postoperative delirium after elective brain tumor resection: retrospective analysis of a prospective cohort. Surgery. 2021;170(6):1763–9. https://doi.org/10.1016/j.surg.2021.05.048.
• Thommen R, Kazim SF, Rumalla K, Kassicieh AJ, Kalakoti P, Schmidt MH, et al. Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis. J Neurooncol. 2022;160(2):285–97. https://doi.org/10.1007/s11060-022-04135-z. Compared the predictive utility of the modified frailty index and risk analysis index among a sample of neuro-oncology patients.
Kassicieh AJ, Rumalla K, Kazim SF, Asserson DB, Schmidt MH, Bowers CA. Preoperative risk model for perioperative stroke after intracranial tumor resection: ACS NSQIP analysis of 30,951 cases. Neurosurg Focus. 2022;53(6):E9. https://doi.org/10.3171/2022.9.Focus22402.
Schmidt AQ, von Euw S, Roy JM, Skandalakis GP, Kazim SF, Schmidt MH, et al. Frailty predicts hospital acquired infections after brain tumor resection: analysis of 27,947 patients’ data from a prospective multicenter surgical registry. Clin Neurol Neurosurg. 2023;229: 107724. https://doi.org/10.1016/j.clineuro.2023.107724.
• Huq S, Liu J, Romano R, Seal S, Khalafallah AM, Walston JD, et al. Frailty in patients undergoing surgery for brain tumors: a systematic review of the literature. World Neurosurg. 2022;166:268-78.e8. https://doi.org/10.1016/j.wneu.2022.07.039. Review that provides an overview of frailty screening tools used within neuro-oncology populations and outlines individual study results.
Qureshi HM, Tabor JK, Pickens K, Lei H, Vasandani S, Jalal MI, et al. Frailty and postoperative outcomes in brain tumor patients: a systematic review subdivided by tumor etiology. J Neurooncol. 2023;164(2):299–308. https://doi.org/10.1007/s11060-023-04416-1.
留言 (0)